| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.7759852759781514 3.2582197442214595 0.0011211355455018 0.4938443479594838 0.3085446631755712 26 Q9BWD1,Q9UBM7,P48449,Q15392,Q15125,P14324,Q16850,P35610,Q14739,P37268 10 |
| Cytoplasmic ribosomal proteins 0.5766862051202964 3.0774586058242197 0.0020877383228572 0.7187698362136554 0.3085446631755712 74 P62750,P23396,P62266,P62910,P61927,P46781,P62424,P61513,P62913,P62906,P84098,P60866,P62899,P39023,P62081,P36578,P26373,P83881,P62847,P62861,P61313,P49207,P46776,Q9Y3U8,P46777,P50914,P62753,P62851,P35268,Q02878,P63173,P46782,P62829,P40429,Q02543,P39019,P46779,P62917,P18124,P62263,P62857,P46778,P62241,P61353,P62277,P47914,P62841,P62701,P83731,Q07020 50 |
| Cholesterol biosynthesis with skeletal dysplasias 0.9502219398815874 2.7062075096803295 0.0068056504769358 0.9841589580997124 0.3085446631755712 7 Q15125,Q15392,Q14739,Q16850 4 |
| Oxysterols derived from cholesterol 0.9045041727843596 2.6181677529309617 0.0088403333669324 0.995437762311814 0.3085446631755712 8 Q15125,P34913 2 |
| 7oxoc and 7betahc pathways 0.7558473625630586 2.2619782786440803 0.0236987453590493 0.9999995242318284 0.4226183182095783 10 Q15125,P34913 2 |
| Allograft rejection 0.7488989673076385 2.2302786963610535 0.025728946575918 0.9999998655260244 0.4226183182095783 10 P08183 1 |
| Ketogenesis and ketolysis 0.8149337921141218 2.1633776184069267 0.0305121475794398 0.9999999932201564 0.4611041311400956 7 O43772 1 |
| Sphingolipid metabolism overview 0.7277277715692948 2.1329973755684803 0.0329249414902732 0.9999999985060678 0.4611041311400956 10 Q96G23,Q06136 2 |
| Sphingolipid metabolism integrated pathway 0.7277277715692948 2.1329973755684803 0.0329249414902732 0.9999999985060678 0.4611041311400956 10 Q96G23,Q06136 2 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.8516607983945415 2.1097597873961047 0.0348790517927088 0.9999999995623596 0.4611041311400956 6 P09601 1 |
| Cholesterol biosynthesis pathway 0.6872456586965296 2.10423264687627 0.035358158034326 0.9999999996762424 0.4611041311400956 14 P48449,P37268,Q9UBM7,Q16850 4 |
| Sphingolipid pathway 0.716485756904166 2.080918989215617 0.0374413217230573 0.9999999999128396 0.4611041311400956 10 Q96G23,Q06136 2 |
| Il10 antiinflammatory signaling pathway 0.8730943391002153 2.0571044193824797 0.0396761827057583 0.9999999999787408 0.4611041311400956 5 P09601 1 |
| Tryptophan metabolism 0.6743486494287103 2.040092321300516 0.0413411313802605 0.9999999999925852 0.4611041311400956 14 P51648,Q15392,P35610 3 |
| Oxidation by cytochrome p450 0.8129863944009573 1.9563153823474275 0.0504280132366483 0.9999999999999772 0.516423124602826 6 O43169,Q16850,Q9UHQ9 3 |
| Progeriaassociated lipodystrophy 0.6873228221276224 1.9444909574570488 0.0518362748119982 0.9999999999999908 0.516423124602826 10 O60725,O75844 2 |
| Metabolism of spingolipids in er and golgi apparatus 0.8427107813019059 1.939543853821764 0.05243515001353 0.9999999999999936 0.516423124602826 5 Q06136 1 |
| Adipogenesis 0.6392012382065517 1.9249780643743235 0.0542321025523153 0.999999999999998 0.516423124602826 15 O75844,P43490 2 |
| Male infertility 0.569932212757478 1.9232402491467968 0.0544498846368712 0.9999999999999982 0.516423124602826 23 Q15165,P08183 2 |
| Ferroptosis 0.5600893926635832 1.894687044424664 0.0581338751395361 1.0 0.534655488025734 24 P16435,P04035,Q9NZZ3,Q16881,P09601,P37268 6 |
| Fatty acid betaoxidation 0.5632873138610194 1.8283532383081944 0.06749655457212 1.0 0.5937740380474905 21 O43772 1 |
| Metapathway biotransformation phase i and ii 0.5409984819954725 1.8087139278332915 0.0704954580684382 1.0 0.6112963292506004 25 P34913,Q16850 2 |
| Proteoglycan biosynthesis 0.7286508953373317 1.7993953756693977 0.0719561605634484 1.0 0.6151744994649747 7 O95340 1 |
| Nad biosynthetic pathways 0.8426302113764104 1.7441567466847216 0.0811317612044426 1.0 0.6654997169067121 4 Q96EB6,P43490 2 |
| Influence of laminopathies on wnt signaling 0.6303664437886825 1.7304418278412723 0.0835513661107896 1.0 0.6673115688059118 12 P50402,O75844 2 |
| G1 to s cell cycle control 0.519871132779974 1.61478029871373 0.1063582810520566 1.0 0.7118944780997858 23 P49736,P11802,Q00534,Q14566,P06493,P33991,Q9Y619,P49642,P14635 9 |
| Camkk2 pathway 0.5895095820212043 1.6083659565354964 0.1077550530534297 1.0 0.7118944780997858 14 Q14683,P28482,Q13501,Q9Y3D6,Q96EB6,P09601 6 |
| Familial partial lipodystrophy fpld 0.6640219806532242 1.5931009495691193 0.1111375463690205 1.0 0.7118944780997858 8 O75844 1 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.6079823223865485 1.5911515257219722 0.1115754789864211 1.0 0.7118944780997858 11 P14324,P37268,Q9BWD1,P35610 4 |
| Nad metabolism sirtuins and aging 0.8026671665081297 1.5902644959378407 0.1117751979647128 1.0 0.7118944780997858 4 Q96EB6,P43490 2 |
| Oxidative stress response 0.7201439364449564 1.578863175467422 0.1143674441039361 1.0 0.7118944780997858 6 P09601 1 |
| Envelope proteins and their potential roles in edmd physiopathology 0.5396117270243505 1.5530785175970463 0.1204043776300456 1.0 0.7118944780997858 18 P36507,P50402,P33176,Q14739,P42166 5 |
| Parkinsons disease pathway 0.6504566771934697 1.5323037844983685 0.1254474876573961 1.0 0.7321790866157638 8 P42574,Q99700,O43464 3 |
| Primary focal segmental glomerulosclerosis fsgs 0.5182095863683982 1.5119623313359298 0.1305434455694833 1.0 0.7384787668655642 20 Q14108 1 |
| Retinoblastoma gene in cancer 0.4213301365662983 1.4601275700014669 0.1442550167404879 1.0 0.7631276934981168 47 P11802,P26583,P09429,P52701,Q14566,P06493,P16949,Q9UQE7,P33991,Q9Y619,P49642,P00374,P14635,P04818,P26358,Q14683,O95347,Q00534,Q14527 19 |
| Sarscov2 and covid19 pathway 0.9606093348591996 1.4477344472426927 0.1476913321293373 1.0 0.7689645588710511 3 Q8WTV0 1 |
| Translation factors 0.4394303194620779 1.4458514603276251 0.1482188688433492 1.0 0.7689645588710511 36 P19525,P11940,Q14152,Q14240,Q9UI10,P26641,Q9NR50,P55010,O60841,Q04637,P63241,Q13347,P23588,Q13144,P24534,P20042,O75153 17 |
| Sterol regulatory elementbinding proteins srebp signaling 0.4345271880826895 1.3887115912431498 0.1649204680556342 1.0 0.8023788732387945 34 P37268,Q8WTV0,Q16850 3 |
| Statin inhibition of cholesterol production 0.6667823336209687 1.3575212882132026 0.174615633985151 1.0 0.8023788732387945 6 P37268,Q8WTV0 2 |
| Interactions between loxl4 and oxidative stress pathway 0.7336665401263651 1.3218389591363522 0.1862217821300464 1.0 0.8023788732387945 4 Q9BQ95,Q96EB6 2 |
| Il9 signaling pathway 0.5868620001918304 1.3146417108241144 0.1886303449357087 1.0 0.8023788732387945 9 P36507,P62993,P27361,P28482,Q02750 5 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5009090169802091 1.2967989980634915 0.1947003555388924 1.0 0.8023788732387945 17 P50402,O75844 2 |
| Interleukin1 induced activation of nfkb 0.8977828966311556 1.269852056101117 0.2041373338532244 1.0 0.8023788732387945 2 Q13501 1 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.6039873617616254 1.2548033742978617 0.209550147371214 1.0 0.8023788732387945 7 Q07157,P18206,P27361,P28482,P06756 5 |
| Apoptosis modulation by hsp70 0.7156818199998106 1.2516452947211028 0.2106991420666095 1.0 0.8023788732387945 4 P42574 1 |
| Sphingolipid metabolism in senescence 0.5298324291321245 1.251231830213164 0.2108499083870043 1.0 0.8023788732387945 13 Q06136 1 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.5179735114499282 1.2348907674483056 0.2168711599884483 1.0 0.8023788732387945 14 Q96EB6,P09874,P17096,P43490 4 |
| Oxidative damage response 0.5991577416411128 1.2334970988425369 0.2173903584443803 1.0 0.8023788732387945 7 P42574 1 |
| Nephrotic syndrome 0.5159964845966272 1.224527414948853 0.2207533308581197 1.0 0.8023788732387945 14 Q14108,O75844 2 |
| Wnt signaling 0.5047263452181057 1.212111623182636 0.2254696550561914 1.0 0.8086553389830755 15 P25054,P68400,P63000,P19784,O75116,Q9HCK8 6 |
| Eicosanoid synthesis 0.8799308954794192 1.2018358760712802 0.2294271225945605 1.0 0.81017978761104 2 Q9H7Z7 1 |
| Met in type 1 papillary renal cell carcinoma 0.4486726481895712 1.1891489500720724 0.2343810589568686 1.0 0.8134670136964315 24 O96013,Q14241,Q9NWH9,P36507,P46108,P63000,P62913,P28482 8 |
| Integrated cancer pathway 0.4975895281585479 1.1738112321383245 0.2404706440127697 1.0 0.8134670136964315 15 P11802,P06493,P42574,P52701,Q92878 5 |
| Epo receptor signaling 0.5708523371310344 1.1727197541595935 0.240908207018222 1.0 0.8134670136964315 8 P36507,P62993,P27361,P28482,Q02750 5 |
| Mitochondrial complex iii assembly 0.5272161698630128 1.1691237165507105 0.2423537898256778 1.0 0.8134670136964315 10 P22695,P14927,Q9UDW1 3 |
| Endothelin pathways 0.5686799987574587 1.1628956997073037 0.2448718223876058 1.0 0.8134670136964315 8 P42892,P00403,P16615,Q05682 4 |
| Serotonin receptor 2 and elksrfgata4 signaling 0.6813598386632276 1.117947294495656 0.2635895041846159 1.0 0.8196741429594927 4 P36507,P28482,P27361 3 |
| Serotonin receptor 467 and nr3c signaling 0.6813598386632276 1.117947294495656 0.2635895041846159 1.0 0.8196741429594927 4 P36507,P28482,P27361 3 |
| Nipbl role in dna damage cornelia de lange syndrome 0.6810834661020935 1.1168736417007927 0.2640483560950302 1.0 0.8196741429594927 4 Q6KC79,Q14676 2 |
| Ccl18 signaling pathway 0.5104967295284044 1.087234469291519 0.2769332009910052 1.0 0.8412359576287648 10 P07196,P00403,P33176 3 |
| Atm signaling in development and disease 0.4288048518953138 1.084239252594779 0.2782587318538203 1.0 0.8412359576287648 25 P05114,Q12888,P06493,Q92878,Q14739,Q14676 6 |
| Pdgfrbeta pathway 0.5630572484934371 1.07455468760468 0.2825741480059389 1.0 0.8412359576287648 7 P19525,Q02750,P62993,P27361 4 |
| Hepatocyte growth factor receptor signaling 0.4946113408757408 1.0711373069151084 0.2841076957395334 1.0 0.8412359576287648 13 Q9NWH9,P36507,P46108,P62993,P28482 5 |
| Nad metabolism 0.8487903225806489 1.0572113261559315 0.2904151518587994 1.0 0.8516038511028562 3 Q96EB6,P43490 2 |
| Smc1smc3 role in dna damage cornelia de lange syndrome 0.5404152222396685 1.0354484368570307 0.300459535142171 1.0 0.8684711325299896 8 Q92878,Q9UQE7,Q14676,Q14683 4 |
| Lung fibrosis 0.5499375449412147 1.0171053601360165 0.3091033106754983 1.0 0.8691244388278767 7 P09601 1 |
| Il7 signaling pathway 0.531728388986789 0.9964949098841543 0.3190097390157527 1.0 0.8691244388278767 8 P36507,P28482,Q02750,P27361 4 |
| Caloric restriction and aging 0.6383917408456834 0.9521175851895978 0.3410373515850791 1.0 0.9079371597023816 4 P43490 1 |
| Spinal cord injury 0.4150329016383588 0.9435968830996908 0.3453756856321894 1.0 0.915471795540345 22 P06493,P42574,P63000,P28482,O75116,P14174,P62942 7 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.5889793635877494 0.9252688103166804 0.3548260983631206 1.0 0.9257701203091604 5 P62942,P27361 2 |
| Tgfbeta receptor signaling 0.5889793635877494 0.9252688103166804 0.3548260983631206 1.0 0.9257701203091604 5 P62942,P27361 2 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.6272057325433541 0.9094526444804074 0.3631112438821047 1.0 0.9257701203091604 4 P28482,P27361 2 |
| Il2 signaling pathway 0.4702853090387148 0.9094323220021798 0.3631219669082715 1.0 0.9257701203091604 11 P36507,P28482,P62753,P62993 4 |
| P38 mapk signaling pathway 0.5115877145774199 0.9068002217040908 0.3645124526423218 1.0 0.9257701203091604 8 P05114,P63000 2 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.4610369087684938 0.90134512239551 0.3674048495751152 1.0 0.9292280987170622 13 O14641,P25054,P68400,P19784,Q9HCK8 5 |
| Amyotrophic lateral sclerosis als 0.4660652657094777 0.8889030959783406 0.3740551614313521 1.0 0.9382292685488872 11 P36507,P07196,P42574 3 |
| Base excision repair 0.421559723132029 0.8778574387675989 0.3800210888519053 1.0 0.9441100602488792 18 P13051,P09429,Q9NRF9,P09874,P18887,Q07864,Q15054 7 |
| Agerage pathway 0.4226678519353921 0.8584770318609718 0.3906291078156485 1.0 0.9441100602488792 17 P26038,P42574,P63000,P28482,P15311 5 |
| Il6 signaling pathway 0.4542505891985342 0.8489566189678642 0.3959054317635297 1.0 0.9441100602488792 12 P36507,P28482,P62993,P63000 4 |
| Nanoparticlemediated activation of receptor signaling 0.510321926461994 0.8458089252122614 0.3976593456432016 1.0 0.9441100602488792 7 P36507,P28482 2 |
| Copper homeostasis 0.4954930116035112 0.8359610159185514 0.4031768346960698 1.0 0.9522503449825462 8 P42574 1 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.5031349891794289 0.81523823805575 0.414935954034676 1.0 0.9651648674672908 7 P36507,P28482 2 |
| Lncrna in canonical wnt signaling and colorectal cancer 0.419730501149219 0.8008315948508034 0.4232291454485217 1.0 0.9731064063911088 16 Q00534,P25054,P68400,P19784,Q9HCK8 5 |
| Regulation of actin cytoskeleton 0.3426929311446159 0.7779110267984589 0.4366214672079467 1.0 0.9796617215192084 44 Q92888,O96013,P15311,P36507,P46108,Q13464,P35241,P25054,O75116,P63000,P28482,Q9Y2A7,Q8N8S7,P35580,Q9UQB8,P26038 16 |
| Tgfbeta signaling pathway 0.3516956549116453 0.7732610937581399 0.4393678762060635 1.0 0.9796617215192084 34 Q9NWH9,P36507,P06493,Q01082,Q13464,P62993,P49790,P63000,Q12931,P28482,Q7Z3T8,P35658 12 |
| Prolactin signaling pathway 0.3812693065598318 0.7670640006337095 0.4430434643277925 1.0 0.9796617215192084 24 P62753,P36507,P42574,P63000,P28482 5 |
| Melatonin metabolism and effects 0.7616970687475643 0.7640505768732383 0.4448371031247062 1.0 0.9796617215192084 3 P42892 1 |
| Glycogen synthesis and degradation 0.3857898948660465 0.7588149774074202 0.4479632448834487 1.0 0.9798298130320112 21 P06737,P0DP25,P46020,P13807,Q04446 5 |
| Preimplantation embryo 0.488187768990304 0.7523385894378603 0.4518474668682626 1.0 0.9798298130320112 7 Q92945,P17096 2 |
| Mirna regulation of prostate cancer signaling pathways 0.4634116810371094 0.7489264839382136 0.4539015167211704 1.0 0.9798298130320112 9 P36507,P28482 2 |
| Neovascularisation processes 0.7564065649294609 0.7467586865897045 0.4552092376853824 1.0 0.9798298130320112 2 P28482 1 |
| Mapk cascade 0.4793127451617711 0.7154937053806624 0.4743040290116138 1.0 0.9945177438669404 7 P36507,P28482,P62993 3 |
| Proteasome degradation 0.3356527539332568 0.7069382699755105 0.4796048401324977 1.0 1.0 42 P25787,P20618,P49721,P60900,P28070,P62191,P28072,O00231 8 |
| Atm signaling pathway 0.3971179273562739 0.6832468604938874 0.4944508663720552 1.0 1.0 16 Q12888,P06493,Q14683,Q92878,P14635,Q14676 6 |
| Cellular proteostasis 0.5210298876822361 0.6634774046381745 0.5070248461123117 1.0 1.0 5 P61758,O15212,Q99471 3 |
| Alzheimers disease and mirna effects 0.3173158544756678 0.6563338752944872 0.5116093260861518 1.0 1.0 93 O00487,O95197,P28482,P45880,P78536,Q96IX5,P0DP25,P16615,P49721,P20618,P62191,Q92542,P19784,P04406,P42574,P28070,P68400,P28072,P21796,P25787,P36507,P60900,Q9BVA1,P33176 24 |
| Nonalcoholic fatty liver disease 0.3117709358058312 0.640647120793187 0.5217519774225869 1.0 1.0 53 P51970,O43676,Q9NX14,P42574,P22695,P14927,Q9UDW1,O95139,P00403,O43674 10 |
| Nuclear receptors metapathway 0.3076979087427509 0.6359787582218065 0.52479026721243 1.0 1.0 55 P08238,P25685,Q99735,P08183,P28370,Q13451,P06493,Q99615,Q14683,P11166,Q13501,Q16881,Q9H2J7,P09601,Q15067 15 |
| Electron transport chain oxphos system in mitochondria 0.3080818578037931 0.624833649452489 0.5320802432863219 1.0 1.0 54 P51970,O95168,O43676,P22695,P14927,Q9UDW1,Q7KZN9,O95139,P00403,O43674 10 |
| Type 2 papillary renal cell carcinoma 0.4337488673360624 0.6210618233293426 0.5345589467100698 1.0 1.0 9 P11166,P23246,Q13617 3 |
| Mitochondrial complex iv assembly 0.4030294433903565 0.6199981588534473 0.535258999090487 1.0 1.0 13 Q7KZN9,Q9Y2R0 2 |
| Extracellular vesiclemediated signaling in recipient cells 0.5480973458590785 0.61910726758606 0.5358456959308135 1.0 1.0 4 Q9NWH9 1 |
| Dna damage response 0.3559112252912551 0.6172115909909017 0.5370951713916821 1.0 1.0 24 P11802,Q00534,P06493,P42574,Q14683,Q92878,P14635,P15927 8 |
| Intraflagellar transport proteins binding to dynein 0.4091733394958283 0.6090456581406143 0.5424941755857331 1.0 1.0 10 Q9BW83,P63167,Q13409 3 |
| Airway smooth muscle cell contraction 0.5038656330365695 0.6006325962808586 0.5480847222386802 1.0 1.0 5 O75116 1 |
| Tnfalpha signaling pathway 0.3649830325107271 0.5934447604744164 0.5528835409997317 1.0 1.0 19 P06737,Q16543,P42574,P62993,P68400,P63000,P27361,Q12931,P28482 9 |
| Pdgf pathway 0.3906806143301499 0.5893612524436278 0.5556189634042246 1.0 1.0 14 P62993,O00401,P27361,P63000,P28482,Q02750,P00403 7 |
| Map3k1 role in promoting and blocking gonadal determination 0.4998831544496817 0.586308509205851 0.5576682138258096 1.0 1.0 5 P28482 1 |
| Mirna regulation of dna damage response 0.3482271591734176 0.5852687246376291 0.5583670408785479 1.0 1.0 25 P11802,Q00534,P06493,P42574,Q14683,Q92878,P14635,P15927 8 |
| Homologous recombination 0.4453747254896429 0.5790171959824739 0.5625775702294749 1.0 1.0 7 Q92878,P49959 2 |
| Nucleotide excision repair in xeroderma pigmentosum 0.3220685583265186 0.5693001730235676 0.569152449422573 1.0 1.0 34 P05114,Q15054,P54727,Q9NRF9,P09874,P18074,P18887,P32780,P15927,P54725 10 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.4704406887430857 0.5640939460015458 0.5726901979494028 1.0 1.0 6 P36507,P28482 2 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.4401263999914528 0.5586627394223104 0.5763919132210613 1.0 1.0 7 Q14683,Q12834 2 |
| Hepatitis c and hepatocellular carcinoma 0.3946760047280073 0.5567820920150768 0.5776763206695847 1.0 1.0 11 P42574,P62993,P63000 3 |
| Nonsmall cell lung cancer 0.3616793830750188 0.556518772843972 0.5778562646654024 1.0 1.0 18 P11802,Q00534,P36507,Q9HC35,P42574,P28482 6 |
| Mevalonate pathway 0.4639749887582086 0.5405498229966795 0.5888179110009772 1.0 1.0 6 P14324,Q9BWD1 2 |
| Pathways affected in adenoid cystic carcinoma 0.3580686205065658 0.5383857954381688 0.5903107308481896 1.0 1.0 18 P36507,Q9UBU8,Q8IWI9 3 |
| Mthfr deficiency 0.4228840699839261 0.5329700443897775 0.5940543166685672 1.0 1.0 8 P35790 1 |
| Alzheimers disease 0.3032027957998469 0.5209948328554275 0.6023703709224175 1.0 1.0 92 O00487,O95197,P28482,P45880,P78536,P0DP25,P16615,P49721,P20618,P62191,Q92542,P19784,P04406,P42574,P28070,P68400,P28072,P21796,P25787,P36507,P60900,Q9BVA1,P33176 23 |
| Ethanol effects on histone modifications 0.3857309913910996 0.5181769669483941 0.6043348035805509 1.0 1.0 11 P00374,P04818,Q9H9T3 3 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.4794824882154448 0.5146665954188357 0.6067860200599982 1.0 1.0 5 P25054 1 |
| Burn wound healing 0.4077151374763803 0.5144948792489982 0.6069060396425314 1.0 1.0 9 P42574 1 |
| Omega3 omega6 fatty acid synthesis 0.4494536864408598 0.4889026091540516 0.624910648410798 1.0 1.0 6 Q15067 1 |
| Nrf2 pathway 0.3296321142572365 0.481429682942717 0.63021114453457 1.0 1.0 25 P25685,Q99735,Q13501,Q16881,Q9H2J7,P09601 6 |
| Kallmann syndrome 0.4695365778842273 0.480905143644919 0.6305839168981635 1.0 1.0 5 P36507,P28482 2 |
| Glycolysis and gluconeogenesis 0.3270186301744585 0.478398884141218 0.6323663276851841 1.0 1.0 26 P04406,P18669,P04075,P06733,O95563,P11166 6 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.3751188938431002 0.473606003191222 0.6357808937769767 1.0 1.0 11 Q9NWH9,P36507,P63000,P28482,P49840 5 |
| Prion disease pathway 0.3964898195264932 0.4706258838996585 0.6379079201986051 1.0 1.0 9 P28482,P42574,Q9UQE7 3 |
| Ddx1 as a regulatory component of the drosha microprocessor 0.5015469393002662 0.4636107363764315 0.6429266608172404 1.0 1.0 4 Q92878 1 |
| Acute viral myocarditis 0.3564868683507622 0.4591677635220485 0.6461136979737818 1.0 1.0 15 Q9NRG0,P11940,P42574,P09874,P28482,Q13418 6 |
| Netrinunc5b signaling pathway 0.3498716315186819 0.4545125886096122 0.6494599333472535 1.0 1.0 16 P42574 1 |
| Myometrial relaxation and contraction pathways 0.3365793228855118 0.434697244585205 0.6637821986917869 1.0 1.0 18 P0DP25,P16615,Q05682 3 |
| Hypothesized pathways in pathogenesis of cardiovascular disease 0.4914562815521198 0.4320995698741331 0.6656690472961004 1.0 1.0 4 P28482 1 |
| H19 action rbe2f1 signaling and cdkbetacatenin activity 0.4319434816527021 0.4291618716534058 0.6678054283521395 1.0 1.0 6 Q16527 1 |
| Hair follicle development cytodifferentiation part 3 of 3 0.6475366119716284 0.4226977423885169 0.6725158029654268 1.0 1.0 3 P78536 1 |
| Aerobic glycolysis 0.3618836055693321 0.4201099290821611 0.6744051495698062 1.0 1.0 11 P11166,P04406,P04075,P06733 4 |
| Bladder cancer 0.390508787334931 0.4121192090283538 0.6802520498567897 1.0 1.0 8 P36507,P28482 2 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.6396889400921717 0.4021275901509409 0.6875901287354536 1.0 1.0 3 P28482,P27361 2 |
| Gastrin signaling pathway 0.3057708914041263 0.3901082249889946 0.696456521067971 1.0 1.0 28 Q07157,P62753,P46108,Q13464,P42574,P62993,P63000,P28482 8 |
| Onecarbon metabolism and related pathways 0.3495095472879733 0.3885935454095909 0.6975768422660584 1.0 1.0 13 P35790,P04818 2 |
| Cori cycle 0.3513709152269033 0.3872692246557346 0.6985569065583648 1.0 1.0 12 P11166,P04406,P04075,P18669 4 |
| Circadian rhythm genes 0.2887286334998744 0.3860319549803663 0.6994730029681644 1.0 1.0 42 P11802,P43490,Q15233,Q8WXF1,Q14103,Q9UNS1,Q96EB6,P23246,O75116,P04818 10 |
| Erk pathway in huntingtons disease 0.6326390915118214 0.3840504130407804 0.7009410830058833 1.0 1.0 3 P42574 1 |
| Extracellular vesicles in the crosstalk of cardiac cells 0.6395047509357915 0.3784484919443182 0.7050974507281982 1.0 1.0 2 Q96HC4 1 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.3459183411860058 0.3745403155022827 0.708002368154542 1.0 1.0 13 P36507,P62753 2 |
| Kisspeptinkisspeptin receptor system in the ovary 0.4133025078808724 0.3690550510317298 0.7120866916922819 1.0 1.0 6 P36507,P28482 2 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.3429987352162579 0.3632789477528982 0.716396517941928 1.0 1.0 13 Q14152,P20042 2 |
| Nucleotide excision repair 0.3080232515741656 0.3631461801448588 0.7164956891028327 1.0 1.0 24 Q15054,P54727,Q9NRF9,P18074,Q07864,P54725,P32780,P15927,P35251 9 |
| Serine metabolism 0.3852392451010931 0.36229595900445 0.7171308776089562 1.0 1.0 7 P34896,P04818 2 |
| Disruption of postsynaptic signaling by cnv 0.3657659666518816 0.3585179533270936 0.7199557348090371 1.0 1.0 9 Q14168,P28482,Q07157,Q06787 4 |
| Joubert syndrome 0.3131832062525542 0.3584532370767658 0.7200041573302809 1.0 1.0 20 Q10713,P36404,P09874,Q8TD19,Q8IW35,Q92878,O43924 7 |
| Vasopressinregulated water reabsorption 0.3253740872397712 0.3492584271900639 0.7268953059055248 1.0 1.0 16 Q15907,P63167,Q9Y6G9,Q14203,Q9UJW0,Q13409 6 |
| Ciliopathies 0.3023686316642918 0.336605326137232 0.7364144406133426 1.0 1.0 24 Q10713,Q9NQH7,Q15051,Q9BW83,O43924 5 |
| Erbb signaling pathway 0.3072405666632237 0.3324181234414592 0.73957355537036 1.0 1.0 20 O96013,Q13177,P36507,P46108,P62993,P27361,P28482,Q13555 8 |
| Measles virus infection 0.301133632256692 0.3309255395878586 0.7407007300416177 1.0 1.0 24 Q00534,P42574,P68400,P19784,P26038 5 |
| Nanomaterial induced apoptosis 0.3734986881931096 0.3250653957490624 0.745131578122689 1.0 1.0 7 P42574,O43464 2 |
| Mitochondrial complex ii assembly 0.615606104232657 0.3166120450776017 0.7515379950059382 1.0 1.0 2 P31040 1 |
| Interferon type i signaling pathways 0.31703752917216 0.3161451048643289 0.7518923723057864 1.0 1.0 16 P46108,P23588,P62753 3 |
| Ectoderm differentiation 0.2999480142561369 0.3154698677705708 0.7524049259233907 1.0 1.0 21 P17480,Q9H6U6,Q5JSH3,Q9UPN9 4 |
| Leptininsulin signaling overlap 0.6095594586812575 0.3018818175980618 0.7627421569624917 1.0 1.0 2 P40763 1 |
| Mitochondrial complex i assembly model oxphos system 0.2850887042809179 0.2985142274527722 0.765310718911012 1.0 1.0 29 P51970,O95168,O43676,Q9NX14,Q96CU9,Q9NPL8,O95139,O43674,Q8TB37 9 |
| Integrinmediated cell adhesion 0.2824577805119523 0.2860584079587723 0.7748333866319772 1.0 1.0 29 Q15942,O96013,P36507,P46108,Q13464,P62993,P63000,P28482,O75116 9 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.3196701583494663 0.2684146464551727 0.7883801667907928 1.0 1.0 11 P28482,P42574 2 |
| Onecarbon metabolism 0.3048177806777942 0.2553198090247658 0.798476101444755 1.0 1.0 15 P26358,P34896,P04818 3 |
| Network map of sarscov2 signaling pathway 0.2769761159938797 0.2325889018248612 0.8160806460544356 1.0 1.0 25 P06493,P42574,P62753 3 |
| Rett syndrome causing genes 0.2977300865555371 0.2318066114014908 0.8166882217572431 1.0 1.0 15 P46108,Q14683,P28370 3 |
| Breast cancer pathway 0.2666525015067275 0.2166049350029035 0.8285162394686609 1.0 1.0 29 P11802,Q00534,P36507,P25054,P62993,P49959,P09874,P68400,P27361,P28482,P19784,Q92878 12 |
| Dna replication 0.2666094383308277 0.2164288108163637 0.8286535106258914 1.0 1.0 29 P33991,Q9Y619,P49642,P49736 4 |
| Liver x receptor pathway 0.5704002303484094 0.2161213274020065 0.828893175679734 1.0 1.0 2 P49327 1 |
| Transsulfuration pathway 0.3307381776239812 0.2074319705528254 0.8356725166417114 1.0 1.0 7 P26358,Q9NZL9,P25325,P23526,Q99707,P48507 6 |
| 15q112 copy number variation syndrome 0.5466589861751237 0.1986666086722265 0.842523545748451 1.0 1.0 3 Q7L576,Q06787 2 |
| Physiological and pathological hypertrophy of the heart 0.3497195417633184 0.1976955986514849 0.8432832335207519 1.0 1.0 6 P28482 1 |
| Hepatitis b infection 0.266363934453737 0.1902037245923037 0.8491494925976573 1.0 1.0 24 P42574 1 |
| Hif1a and pparg regulation of glycolysis 0.3972270600802153 0.1901035462206222 0.8492279912736485 1.0 1.0 4 P11166 1 |
| Chromosomal and microsatellite instability in colorectal cancer 0.2689635448493226 0.187577909161549 0.8512075447699525 1.0 1.0 20 Q9UKG1,P25054,P42574,P63000,P28482,P52701 6 |
| Transsulfuration and onecarbon metabolism 0.2701783079069256 0.1837389532368556 0.8542182488436543 1.0 1.0 19 P31153,O43865,P26358,Q9NZL9,O43175,P34896,P00374,P48507,P04818 9 |
| Cardiac hypertrophic response 0.287167366713879 0.1755835088509955 0.8606211590936286 1.0 1.0 11 P36507,P28482 2 |
| Disorders of folate metabolism and transport 0.3067358531791108 0.1691104244920094 0.8657097854688875 1.0 1.0 8 P04818 1 |
| Translation inhibitors in chronically activated pdgfra cells 0.2640867011214297 0.1652982059004953 0.8687092708801616 1.0 1.0 19 P62753,Q14240,P36507,P28482,P23588 5 |
| Arrhythmogenic right ventricular cardiomyopathy 0.2761481610596716 0.1597714675539001 0.8730611009071236 1.0 1.0 14 P50402,P16615 2 |
| Rac1pak1p38mmp2 pathway 0.2684137870543081 0.1562907726921006 0.8758038292882138 1.0 1.0 16 P16949,P46108,P62993,P63000,P28482 5 |
| Notch signaling 0.2990130279744918 0.1529627721056736 0.8784276332974863 1.0 1.0 8 Q92542,P78536 2 |
| Embryonic stem cell pluripotency pathways 0.2660213790106291 0.1420917856710976 0.8870075064284966 1.0 1.0 15 P36507,P25054,P28482,P62993 4 |
| Ras and bradykinin pathways in covid19 0.367236078538395 0.136775327867058 0.8912083858500834 1.0 1.0 4 P28482 1 |
| Ranklrank signaling pathway 0.257237613949721 0.1363629853726149 0.8915343336919652 1.0 1.0 17 P28482,Q13501,O95340 3 |
| Microtubule cytoskeleton regulation 0.2514400237116002 0.136050369445955 0.8917814620524136 1.0 1.0 20 P16949,P06493,P25054,Q13464,P63000,Q99661 6 |
| Ciliary landscape 0.2258122716534021 0.1326981049189391 0.8944321416669783 1.0 1.0 120 Q9UPT5,P07196,Q12904,P63167,P43034,Q9BW83,O75663,Q8IVV7,Q14566,Q96PK6,Q99627,P33991,O60841,P49736,Q9NQH7,P63000,Q15051,Q9UNS2,Q13409,O43464,Q9UBW8,Q9NTJ3,O43805,O15173 24 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.2644399840166651 0.1319467127805635 0.8950264401469852 1.0 1.0 14 Q13501,Q8NC51 2 |
| Tcell receptor tcr signaling pathway 0.2507432610282313 0.1289100062949255 0.8974288588586976 1.0 1.0 19 P46108,P28482,P36507,P62993 4 |
| Inclusion body myositis 0.497133409236546 0.1249065575386638 0.9005975268672155 1.0 1.0 3 Q96EB6 1 |
| Mitochondrial gene expression 0.3098875756702225 0.1217120380082698 0.9031270791707422 1.0 1.0 6 P51610,O00411,Q00059,Q16566,Q8WVM0 5 |
| Photodynamic therapyinduced unfolded protein response 0.2624113030939698 0.1205121352157448 0.90407746719306 1.0 1.0 10 P23381,P08243 2 |
| Endometrial cancer 0.2549985900485355 0.1170823923546301 0.9067947626272236 1.0 1.0 15 P36507,P25054,P62993,P28482,Q13418 5 |
| T cell receptor and costimulatory signaling 0.3233429394812608 0.1166883199939154 0.9071070463357418 1.0 1.0 5 P19174,P49840,P49841,P48729 4 |
| Alpha 6 beta 4 signaling pathway 0.2536348974946825 0.1048400416199167 0.9165027364922822 1.0 1.0 11 P28482,P62993,P63000 3 |
| Cell cycle 0.2266965736543936 0.1046673621607421 0.9166397608927848 1.0 1.0 50 P49736,P11802,Q00534,Q14566,P06493,Q9UQE7,Q14683,P33991,Q9Y619,Q12834 10 |
| Gastric cancer network 1 0.2650877757307933 0.10331398449878 0.9177137769870742 1.0 1.0 9 P33991,Q9ULW0 2 |
| Fluoropyrimidine activity 0.2521713874540159 0.1028050318902755 0.9181177115576054 1.0 1.0 13 P18074 1 |
| Tumor suppressor activity of smarcb1 0.2421982490737457 0.0964224355116388 0.9231850741793346 1.0 1.0 16 Q92785,Q00534,Q8TAQ2 3 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.3334700296011755 0.0914403572890273 0.9271426955721382 1.0 1.0 4 P28482 1 |
| Striated muscle contraction pathway 0.3014409221901933 0.0881995871295557 0.9297180454625896 1.0 1.0 5 O43707,P06753,P08670,P67936 4 |
| Endoplasmic reticulum stress response in coronavirus infection 0.2590135563888129 0.0875098847382855 0.9302662286901486 1.0 1.0 8 P05198,P62140,Q96QC0,P19525,Q12972,O14974,P62136 7 |
| Pancreatic adenocarcinoma pathway 0.228692027930094 0.0847202842796348 0.9324837694198274 1.0 1.0 24 O96013,P11802,Q00534,P36507,P30086,P63000,P28482 7 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.2478320420711539 0.0794552380127445 0.9366705338909038 1.0 1.0 9 P28482,Q8WUM4,P27361 3 |
| Mbdnf and probdnf regulation of gaba neurotransmission 0.2489183732333469 0.0756196075299378 0.9397217365753884 1.0 1.0 8 P40763,P19174,Q13464,P63010,O95782,P61586,O00459 7 |
| Sudden infant death syndrome sids susceptibility pathways 0.220773180530997 0.0748918916073052 0.9403007280003453 1.0 1.0 30 P42574 1 |
| Focal adhesion 0.2169758258739769 0.0671215324214088 0.9464849521558164 1.0 1.0 41 Q15942,O96013,Q13017,Q13177,Q9NWH9,P46108,Q13464,O43707,P62993,P63000,P27361,P28482,Q13418,O75116,P06756 15 |
| Methylation pathways 0.3039469893402565 0.0637367357429988 0.9491798533076536 1.0 1.0 4 P31153,Q9NZL9,P51580 3 |
| Physicochemical features and toxicityassociated pathways 0.2160393310254359 0.0598766642175596 0.952253865797038 1.0 1.0 19 P07196,P28482,P62993,O75116 4 |
| Urea cycle and metabolism of amino groups 0.2202734704555279 0.0498756193011039 0.9602215060962196 1.0 1.0 7 P32322,P00367,P54886 3 |
| Hematopoietic stem cell gene regulation by gabp alphabeta complex 0.4000566046201818 0.0474195229012245 0.9621788694966718 1.0 1.0 3 P26358 1 |
| Folatealcohol and cancer pathway hypotheses 0.4235531241002078 0.0466258629630438 0.9628114187790706 1.0 1.0 2 Q99707 1 |
| Alanine and aspartate metabolism 0.2083573487031636 0.0316994692429688 0.9747117181580665 1.0 1.0 5 P14868,P80404,P00505,P17174 4 |
| Wnt signaling in kidney disease 0.3245967741935547 0.0291887906579953 0.976714021185138 1.0 1.0 3 O14641,P35222 2 |
| G13 signaling pathway 0.1879250441978434 0.0281587638755392 0.9775355258317412 1.0 1.0 18 O75116,Q13464,P63000 3 |
| Hair follicle development organogenesis part 2 of 3 0.3018433179723526 0.0272875330717416 0.978230400334827 1.0 1.0 3 Q9BZE4,P35222 2 |
| Pkcgamma calcium signaling pathway in ataxia 0.3230636337460384 0.0251684187509716 0.9799206271586084 1.0 1.0 2 P29992 1 |
| Notch signaling pathway 0.1742934121686896 0.0235076236381551 0.9812453573826032 1.0 1.0 14 Q92542,P78536 2 |
| Pathogenic escherichia coli infection 0.1613198864694403 0.0039150310295807 0.9968762651662596 1.0 1.0 27 Q9BVA1,P15311 2 |
|
|
